Synergetic B-Cell Immunomodulation with Rituximab and Belimumab Combination Treatment in Severe, Refractory SLE

Author(s):
Kraaij, T.; Kamerling, S.W.A.; Rooij, E.N.M. de; Daele, P.L. van; Bredewold, O.W.; Bakker, J.A. (0000-0002-2918-7361); Bajema, I.; Scherer, H.U. (0000-0002-5700-5617); Toes, R.E.M. (0000-0002-9618-6414); Huizinga, T.W.J. (0000-0001-7033-7520); Rabelink, T.; Kooten, C. van (0000-0002-6257-0899); Teng, Y.K.O.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-10-31
Language
English
Is part of
Arthritis and Rheumatology
hdl
1887/114915